GLS and cancer: As our results demonstrate that glutamine deprivation induces autophagy (Figure 1), we investigated the therapeutical benefit of a combination of glutaminase inhibitors with the V-ATPase inhibitor archazolid, a known anti-cancer compound that inhibits autophagy.